Researchers generated a virus-like particle (VLP) vaccine bearing the hemagglutinin of H1N1 A/California/07/09 that was unable to bind to its α(2,6)-linked sialic acid receptor and compared its immunogenicity and efficacy to a wild-type H1-VLP in mice.
[NPJ Vaccines]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
173973
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
